Octamer binding protein 2 (Oct2) regulates PD-L2 gene expression in B-1 cells through lineage-specific activity of a unique, intronic promoter

Genes and Immunity

Volumn 11, Issue 1, 2010, Pages 55-66

  Kaku, H ^a   Rothstein, T L ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

B lymphocyte; B 1 cells; Intronic promoter; Oct1; Oct2; PD L2

Indexed keywords

MEMBRANE PROTEIN; OCTAMER TRANSCRIPTION FACTOR 1; OCTAMER TRANSCRIPTION FACTOR 2; PROGRAMMED DEATH 1 LIGAND 2;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL LINEAGE; CELL SPECIFICITY; CONTROLLED STUDY; EXON; GENE EXPRESSION REGULATION; INTRON; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; B-LYMPHOCYTES; CELL LINE, TUMOR; GENE EXPRESSION REGULATION; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; OCTAMER TRANSCRIPTION FACTOR-1; OCTAMER TRANSCRIPTION FACTOR-2; ORGAN SPECIFICITY; PEPTIDES; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC;

EID: 75049083688     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2009.68     Document Type: Article

References (50)

1. Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 2008; 26: 677-704.
2. Okazaki T, Iwai Y, Honjo T. New regulatory co-receptors: inducible co-stimulator and PD-1. Curr Opin Immunol 2002; 14: 779-782.
3. Okazaki T, Honjo T. The PD-1PD-L pathway in immunological tolerance. Trends Immunol 2006; 27: 195-201.
4. Nishimura H, Nose M, Hiai H, Minato N, Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999; 11: 141-151.
5. Nishimura H, Okazaki T, Tanaka Y, Nakatani K, Hara M, Matsumori A et al. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 2001; 291: 319-322.
6. Okazaki T, Tanaka Y, Nishio R, Mitsuiye T, Mizoguchi A, Wang J et al. Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat Med 2003; 9: 1477-1483.
7. Nishimura H, Minato N, Nakano T, Honjo T. Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses. Int Immunol 1998; 10: 1563-1572.
8. Iwai Y, Terawaki S, Ikegawa M, Okazaki T, Honjo T. PD-1 inhibits antiviral immunity at the effector phase in the liver. J Exp Med 2003; 198: 39-50.
9. Dong H, Zhu G, Tamada K, Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and inter-leukin-10 secretion. Nat Med 1999; 5: 1365-1369.
10. Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 2000; 192: 1027-1034.
11. Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M, Chernova I et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2001; 2: 261-268.
12. Tseng SY, Otsuji M, Gorski K, Huang X, Slansky JE, Pai SI et al. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J Exp Med 2001; 193: 839-846.
13. Liang SC, Latchman YE, Buhlmann JE, Tomczak MF, Horwitz BH, Freeman GJ et al. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur J Immunol 2003; 33: 2706-2716.
14. Brown JA, Dorfman DM, Ma FR, Sullivan EL, Munoz O, Wood CR et al. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J Immunol 2003; 170: 1257-1266.
15. Nakae S, Suto H, Iikura M, Kakurai M, Sedgwick JD, Tsai M et al. Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J Immunol 2006; 176: 2238-2248.
16. Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol 2007; 8: 239-245.
17. Zhu B, Guleria I, Khosroshahi A, Chitnis T, Imitola J, Azuma M et al. Differential role of programmed death-ligand 1 and programmed death-ligand 2 in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis. J Immunol 2006; 176: 3480-3489.
18. Carter LL, Leach MW, Azoitei ML, Cui J, Pelker JW, Jussif J et al. PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis. J Neuroimmunol 2007; 182: 124-134.
19. Ito T, Ueno T, Clarkson MR, Yuan X, Jurewicz MM, Yagita H et al. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo. J Immunol 2005; 174: 6648-6656.
20. Hori J, Wang M, Miyashita M, Tanemoto K, Takahashi H, Takemori T et al. B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts. J Immunol 2006; 177: 5928-5935.
21. Sandner SE, Clarkson MR, Salama AD, Sanchez-Fueyo A, Domenig C, Habicht A et al. Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo. J Immunol 2005; 174: 3408-3415.
22. Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 2002; 8: 793-800.
23. Liu X, Gao JX, Wen J, Yin L, Li O, Zuo T et al. B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism. J Exp Med 2003; 197: 1721-1730.
24. Liang SC, Greenwald RJ, Latchman YE, Rosas L, Satoskar A, Freeman GJ et al. PD-L1 and PD-L2 have distinct roles in regulating host immunity to cutaneous leishmaniasis. Eur J Immunol 2006; 36: 58-64.
25. Radhakrishnan S, Nguyen LT, Ciric B, Ure DR, Zhou B, Tamada K et al. Naturally occurring human IgM antibody that binds B7-DC and potentiates T cell stimulation by dendritic cells. J Immunol 2003; 170: 1830-1838.
26. Van Keulen VP, Ciric B, Radhakrishnan S, Heckman KL, Mitsunaga Y, Iijima K et al. Immunomodulation using the recombinant monoclonal human B7-DC cross-linking antibody rHIgM12. Clin Exp Immunol 2006; 143: 314-321.
27. Blocki FA, Radhakrishnan S, Van Keulen VP, Heckman KL, Ciric B, Howe CL et al. Induction of a gene expression program in dendritic cells with a cross-linking IgM antibody to the co-stimulatory molecule B7-DC. FASEB J 2006; 20: 2408-2410.
28. Radhakrishnan S, Nguyen LT, Ciric B, Van Keulen VP, Pease LR. B7-DC/PD-L2 cross-linking induces NF-kappaB-depen-dent protection of dendritic cells from cell death. J Immunol 2007; 178: 1426-1432.
29. Kuipers H, Muskens F, Willart M, Hijdra D, van Assema FB, Coyle AJ et al. Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation. Eur J Immunol 2006; 36: 2472-2482.
30. Wang SC, Lin CH, Ou TT, Wu CC, Tsai WC, Hu CJ et al. Ligands for programmed cell death 1 gene in patients with systemic lupus erythematosus. J Rheumatol 2007; 34: 721-725.
31. Zhong X, Tumang JR, Gao W, Bai C, Rothstein TL. PD-L2 expression extends beyond dendritic cells/macrophages to B1 cells enriched for V(H)11/V(H)12 and phosphatidylcholine binding. Eur J Immunol 2007; 37: 2405-2410.
32. Yamazaki T, Akiba H, Iwai H, Matsuda H, Aoki M, Tanno Y et al. Expression of programmed death 1 ligands by murine T cells and APC. J Immunol 2002; 169: 5538-5545.
33. Kantor AB, Herzenberg LA. Origin of murine B cell lineages. Annu Rev Immunol 1993; 11: 501-538.
34. Briles DE, Forman C, Hudak S, Claflin JL. Anti-phosphor-ylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae. J Exp Med 1982; 156: 1177-1185.
35. Boes M, Prodeus AP, Schmidt T, Carroll MC, Chen J. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med 1998; 188: 2381-2386.
36. Ochsenbein AF, Fehr T, Lutz C, Suter M, Brombacher F, Hengartner H et al. Control of early viral and bacterial distribution and disease by natural antibodies. Science 1999; 286: 2156-2159.
37. Baumgarth N, Herman OC, Jager GC, Brown LE, Herzenberg LA, Chen J. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med 2000; 192: 271-280.
38. Haas KM, Poe JC, Steeber DA, Tedder TF. B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity 2005; 23: 7-18.
39. Montecino-Rodriguez E, Leathers H, Dorshkind K. Identification of a B-1 B cell-specified progenitor. Nat Immunol 2006; 7: 293-301.
40. Zhong X, Lau S, Bai C, Degauque N, Holodick NE, Steven SJ et al. A novel subpopulation of B1 B cells is enriched with autoreactivity in normal and lupus-prone mice. Arthr Rheum 2009; (in press).
41. Zhao FQ, Zheng Y, Dong B, Oka T. Cloning, genomic organization, expression, and effect on beta-casein promoter activity of a novel isoform of the mouse Oct-1 transcription factor. Gene 2004; 326: 175-187.
42. Pevzner V, Kraft R, Kostka S, Lipp M. Phosphorylation of Oct-2 at sites located in the POU domain induces differential downregulation of Oct-2 DNA-binding ability. Biochem J 2000; 347: 29-35.
43. Kemler I, Schaffner W. Octamer transcription factors and the cell type-specificity of immunoglobulin gene expression. FASEB J 1990; 4: 1444-1449.
44. Tumang JR, Frances R, Yeo SG, Rothstein TL. Cutting edge: spontaneously Ig-secreting B-1 cells violate the accepted paradigm for expression of differentiation-associated transcription factors. J Immunol 2005; 174: 3173-3177.
45. Rothstein TL, Wang JK, Panka DJ, Foote LC, Wang Z, Stanger B et al. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 1995; 374: 163-165.
46. Shen Q, Zhang W, Cao X, Mou J, Cui L, Hua X. Cloning of full genome sequence of hepatitis E virus of Shanghai swine isolate using RACE method. Virol J 2007; 4: 98.
47. Repetny KJ, Zhong X, Holodick NE, Rothstein TL, Hansen U. LBP-1a binds a subset of immunoglobulin switch regions in vivo and represses class switch recombination. Eur J Immunol 2009; 39: 1387-1394.
48. Frances R, Tumang JR, Rothstein TL. Cutting edge: B-1 cells are deficient in Lck: defective B cell receptor signal transduc-tion in B-1 cells occurs in the absence of elevated Lck expression. J Immunol 2005; 175: 27-31.
49. Mizuno T, Rothstein TL. Cutting edge: CD40 engagement eliminates the need for Bruton's tyrosine kinase in B cell receptor signaling for NF-kappa B. J Immunol 2003; 170: 2806-2810.
50. Tumang JR, Hastings WD, Bai C, Rothstein TL. Peritoneal and splenic B-1 cells are separable by phenotypic, functional, and transcriptomic characteristics. Eur J Immunol 2004; 34: 2158-2167.